Author

Adam Eugene Snook

Thomas Jefferson UniversityORCID 0000-0001-9216-4560Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Approach:statistical model· 1

Frequent Co-Authors

Aaron R. HaeusleriD· 1 shared Adam LuginbuhliD· 1 shared Adi CaspiiD· 1 shared Alice P. PentlandiD· 1 shared Allison S. DoermanniD· 1 shared Amritha AchuthkumariD· 1 shared Ana M PivovarnikiD· 1 shared Andrea FeciiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Aaron R. HaeuslerORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 6, 2026

p38α MAPK integrates opposing oncogenic APC/β-catenin/TCF and GUCY2C tumor-suppressor axes in colorectal cancer

Ariana A. Entezari, Adi Caspi, Jasmine R. Alvarez…·Scott Arthur Waldman

This study shows p38α MAPK links oncogenic APC/β-catenin/TCF signaling with the GUCY2C tumor-suppressor axis in colorectal cancer by regulating hormone expression and signaling pathways.

DOI 10.64898/2026.10.05.756833

humanbulk RNA-seq

𝕏 PostBluesky

BioengineeringbioRxivPreprintMay 3, 2026

Translational Opportunity of Engineered IFNγ-eEVs Through Targeted Inhibition of JAK/STAT1 Signaling, Mimicking IVIg Therapy

Kylie E Preihs, Kübra Karagoz, Claire R Shuey…·My G Mahoney

This paper identifies EV-associated cytokines as mediators of IVIg activity, showing that engineered IFNγ-eEVs can suppress IFNγ signaling through context-dependent mechanisms.

DOI 10.64898/2026.04.29.721601

humanproteomics

𝕏 PostBluesky

NeurosciencebioRxivPreprintDec 29, 2025

A CAR-T Cell-Based Strategy for Eliminating Pathogenic Microglia in ALS

M.E. Cicardi, Daniela Tejada-Martínez, Shashirekha S. Markandaiah…·Davide Trotti

CAR-T cells targeting uPAR selectively ablate pathogenic microglia while sparing neurons, enabling precision immunotherapy for ALS.

DOI 10.64898/2025.12.29.696307

humanproteomics

𝕏 PostBluesky